Risultati della ricerca - Arlene Naranjo

Raffina i risultati
  1. 1
    The ganglioside G<sub>D2</sub> as a circulating tumor biomarker for neuroblastoma

    The ganglioside G<sub>D2</sub> as a circulating tumor biomarker for neuroblastoma di Frank M. Balis, Christine M. Busch, Ami V. Desai, Emily Hibbitts, Arlene Naranjo, Rochelle Bagatell, Meredith S. Irwin, Elizabeth Fox

    Pubblicazione 2019
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  2. 2
    Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and Future

    Tailoring Therapy for Children With Neuroblastoma on the Basis of Risk Group Classification: Past, Present, and Future di Wayne H. Liang, Sara M. Federico, Wendy B. London, Arlene Naranjo, Meredith S. Irwin, Samuel L. Volchenboum, Susan L. Cohn

    Pubblicazione 2020
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  3. 3
    Children's Oncology Group's 2023 blueprint for research: Neuroblastoma

    Children's Oncology Group's 2023 blueprint for research: Neuroblastoma di Rochelle Bagatell, Steven G. DuBois, Arlene Naranjo, J. S. Van Belle, Kelly C. Goldsmith, Julie R. Park, Meredith S. Irwin

    Pubblicazione 2023
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  4. 4
    Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early‐phase trials

    Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group earl... di Wendy B. London, Rochelle Bagatell, Brenda J. Weigel, Elizabeth Fox, Dongjing Guo, Collin Van Ryn, Arlene Naranjo, Julie R. Park

    Pubblicazione 2017
    Testo Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  5. 5
    Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2

    Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2 di James I. Geller, Peter F. Ehrlich, Nicholas G. Cost, Geetika Khanna, Elizabeth A. Mullen, Eric J. Gratias, Arlene Naranjo, Jeffrey S. Dome, Elizabeth J. Perlman

    Pubblicazione 2015
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  6. 6
    Comparison of diagnostic performance of CT and MRI for abdominal staging of pediatric renal tumors: a report from the Children’s Oncology Group

    Comparison of diagnostic performance of CT and MRI for abdominal staging of pediatric renal tumors: a report from the Children’s Oncology Group di Sabah Servaes, Geetika Khanna, Arlene Naranjo, James I. Geller, Peter F. Ehrlich, Kenneth W. Gow, Elizabeth J. Perlman, Jeffrey S. Dome, Eric J. Gratias, Elizabeth A. Mullen

    Pubblicazione 2014
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  7. 7
    Pilot Induction Regimen Incorporating Pharmacokinetically Guided Topotecan for Treatment of Newly Diagnosed High-Risk Neuroblastoma: A Children's Oncology Group Study

    Pilot Induction Regimen Incorporating Pharmacokinetically Guided Topotecan for Treatment of Newly Diagnosed High-Risk Neuroblastoma: A Children's Oncology Group Study di Julie R. Park, Jeffrey R. Scott, Clinton F. Stewart, Wendy B. London, Arlene Naranjo, Victor M. Santana, Peter J. Shaw, Susan L. Cohn, Katherine K. Matthay

    Pubblicazione 2011
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  8. 8
    Predictors of differential response to induction therapy in high-risk neuroblastoma: A report from the Children's Oncology Group (COG)

    Predictors of differential response to induction therapy in high-risk neuroblastoma: A report from the Children's Oncology Group (COG) di Navin Pinto, Arlene Naranjo, Emily Hibbitts, Susan G. Kreissman, Meaghan Granger, Meredith S. Irwin, Rochelle Bagatell, Wendy B. London, Emily Greengard, Julie R. Park, Steven G. DuBois

    Pubblicazione 2019
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  9. 9
    Detection of Preoperative Wilms Tumor Rupture with CT: A Report from the Children’s Oncology Group

    Detection of Preoperative Wilms Tumor Rupture with CT: A Report from the Children’s Oncology Group di Geetika Khanna, Arlene Naranjo, Fredric A. Hoffer, Elizabeth A. Mullen, James I. Geller, Eric J. Gratias, Peter F. Ehrlich, Elizabeth J. Perlman, Nancy Rosen, Paul E. Grundy, Jeffrey S. Dome

    Pubblicazione 2012
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  10. 10
    Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial

    Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomis... di Pedro A. de Alarcón, Katherine K. Matthay, Wendy B. London, Arlene Naranjo, Sheena C. Tenney, Jessica A. Panzer, Michael D. Hogarty, Julie R. Park, John M. Maris, Susan L. Cohn

    Pubblicazione 2017
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  11. 11
    Poverty and Targeted Immunotherapy: Survival in Children’s Oncology Group Clinical Trials for High-Risk Neuroblastoma

    Poverty and Targeted Immunotherapy: Survival in Children’s Oncology Group Clinical Trials for High-Risk Neuroblastoma di Kira Bona, Yimei Li, Lena E. Winestone, Kelly Getz, Yuan‐Shung Huang, Brian T. Fisher, Ami V. Desai, Troy Richardson, Matt Hall, Arlene Naranjo, Tara O. Henderson, Richard Aplenc, Rochelle Bagatell

    Pubblicazione 2020
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  12. 12
    A Prospective Study of Expectant Observation as Primary Therapy for Neuroblastoma in Young Infants

    A Prospective Study of Expectant Observation as Primary Therapy for Neuroblastoma in Young Infants di Jed G. Nuchtern, Wendy B. London, Carol E. Barnewolt, Arlene Naranjo, Patrick McGrady, James D. Geiger, Lisa Diller, Mary Lou Schmidt, John M. Maris, Susan L. Cohn, Robert C. Shamberger

    Pubblicazione 2012
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  13. 13
    Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children’s Oncology Group

    Semiquantitative mIBG Scoring as a Prognostic Indicator in Patients with Stage 4 Neuroblastoma: A Report from the Children’s Oncology Group di Gregory A. Yanik, Marguerite T. Parisi, Barry L. Shulkin, Arlene Naranjo, Susan G. Kreissman, Wendy B. London, Judith G. Villablanca, John M. Maris, Julie R. Park, Susan L. Cohn, Patrick McGrady, Katherine K. Matthay

    Pubblicazione 2013
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  14. 14
    Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children’s Oncology Group Study ANBL0531

    Defining Risk Factors for Chemotherapeutic Intervention in Infants With Stage 4S Neuroblastoma: A Report From Children’s Oncology Group Study ANBL0531 di Clare J. Twist, Arlene Naranjo, Mary Lou Schmidt, Sheena C. Tenney, Susan L. Cohn, Holly J. Meany, Peter Mattei, E. Stanton Adkins, Hiroyuki Shimada, Wendy B. London, Julie R. Park, Katherine K. Matthay, John M. Maris

    Pubblicazione 2018
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  15. 15
    Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project

    Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project di Elizabeth Sokol, Ami V. Desai, Mark A. Applebaum, Dominique Valteau‐Couanet, Julie R. Park, Andrew D.J. Pearson, Gudrun Schleiermacher, Meredith S. Irwin, Michael D. Hogarty, Arlene Naranjo, Samuel L. Volchenboum, Susan L. Cohn, Wendy B. London

    Pubblicazione 2020
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  16. 16
    Children's Oncology Group's 2013 blueprint for research: Renal tumors

    Children's Oncology Group's 2013 blueprint for research: Renal tumors di Jeffrey S. Dome, Conrad V. Fernandez, Elizabeth A. Mullen, John A. Kalapurakal, James I. Geller, Vicki Huff, Eric J. Gratias, David Dix, Peter F. Ehrlich, Geetika Khanna, Marcio H. Malogolowkin, James R. Anderson, Arlene Naranjo, Elizabeth J. Perlman

    Pubblicazione 2012
    Testo
    Revisão
    Aggiungi alla lista
    Salvato in:
  17. 17
    Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: A report from the CCG and COG

    Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: A report from the CCG and COG di Chizuko Okamatsu, Wendy B. London, Arlene Naranjo, Michael D. Hogarty, Julie M. Gastier‐Foster, A. Thomas Look, Michael P. LaQuaglia, John M. Maris, Susan L. Cohn, Katherine K. Matthay, Robert C. Seeger, Tsutomu Saji, Hiroyuki Shimada

    Pubblicazione 2009
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  18. 18
    A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children’s Oncology Group study ANBL00P1

    A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children’s Oncology Group study ANBL00P1 di Alix E. Seif, Arlene Naranjo, David L. Baker, Nancy Bunin, Morris Kletzel, C. Kretschmar, John M. Maris, Patrick McGrady, Daniel von Allmen, Susan L. Cohn, Wendy B. London, J R Park, Lisa Diller, Stephan A. Grupp

    Pubblicazione 2013
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  19. 19
    Association of <i>MYCN</i> copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group

    Association of <i>MYCN</i> copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology Group di Kevin Campbell, Julie M. Gastier‐Foster, Meegan Mann, Arlene Naranjo, Collin Van Ryn, Rochelle Bagatell, Katherine K. Matthay, Wendy B. London, Meredith S. Irwin, Hiroyuki Shimada, Meaghan Granger, Michael D. Hogarty, Julie R. Park, Steven G. DuBois

    Pubblicazione 2017
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  20. 20
    Racial and Ethnic Survival Disparities Among Children With High-Risk Neuroblastoma

    Racial and Ethnic Survival Disparities Among Children With High-Risk Neuroblastoma di Puja J. Umaretiya, Arlene Naranjo, Fan F. Zhang, Julie R. Park, Brian Weiss, Meaghan Granger, Ami V. Desai, M. Fevzi Özkaynak, Alice L. Yu, Rahela Aziz‐Bose, Sandi L. Pruitt, Steven G. DuBois, Rochelle Bagatell, Kira Bona

    Pubblicazione 2025
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: